This expert consensus provides adapted protocols for the diagnosis and management of fulminant myocarditis in patients with COVID-19.
Answers are grounded in this paper and cite their sources.
Guides diagnosis and management of fulminant myocarditis in COVID-19; extends prior consensus to pandemic-specific protocols.
The article contains Russian expert consensus statement on the diagnosis and treatment of fulminant myocarditis (FM), prepared by the National Society for the Study of Lipidology and Associated Metabolic Diseases, the Society of Internal, Sports and Preventive Medicine based on the clinical guidelines of the Russian Society of Cardiology, results of China Clinical Study (NCT03268642), Expert Guidelines of Russian Clinical and Research Center of Gerontology, Chinese Society of Geriatrics, Cardiology Branch of Beijing Medical Association. Pathogenesis, diagnosis and treatment of myocardial injury and FM in patients infected with SARS-CoV-2 in the context of the COVID-19 pandemic are discussed. Clinical features and diagnostic criteria of FM, as well as and comprehensive therapy for myocardial injury and FM are presented. The proposed protocol for the management of patients with myocardial injury in patients infected with SARS-CoV-2 was adapted with the clinical experience of Chinese experts. The protocol for anticoagulant and antiplatelet therapy was proposed by the Moscow State University Medical Center.
No takes yet. Share an insight, caveat, or question.
Oynotkinova et al. (2020) conducted a review in Fulminant myocarditis and myocardial injury in COVID-19. Diagnosis and treatment protocols was evaluated. This expert consensus statement outlines the pathogenesis, diagnostic criteria, and comprehensive management protocols for fulminant myocarditis and myocardial injury in patients with COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: